| Code | Description | Claims | Beneficiaries | Total Paid |
| 99233 |
Prolong inpt eval add15 m |
37,161 |
12,303 |
$1.13M |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
7,341 |
2,892 |
$201K |
| 99223 |
Prolong inpt eval add15 m |
2,717 |
2,004 |
$184K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,269 |
1,202 |
$94K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
348 |
186 |
$68K |
| 95117 |
|
2,046 |
927 |
$35K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
1,139 |
973 |
$31K |
| 99222 |
Initial hospital care, per day, moderate complexity |
428 |
298 |
$23K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
145 |
138 |
$11K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
301 |
264 |
$11K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
40 |
38 |
$8K |
| 95012 |
|
245 |
237 |
$4K |
| 94010 |
|
153 |
149 |
$4K |
| 99220 |
|
37 |
30 |
$4K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
15 |
15 |
$2K |
| 94060 |
|
29 |
29 |
$1K |
| 95115 |
|
55 |
33 |
$733.30 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
40 |
39 |
$650.66 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
27 |
27 |
$587.76 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
4,734 |
3,553 |
$1.16 |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
12 |
12 |
$0.00 |
| 1111F |
|
13 |
12 |
$0.00 |
| 1124F |
|
212 |
180 |
$0.00 |